Skip to main content
. 2023 Sep 18;14:1243946. doi: 10.3389/fimmu.2023.1243946

Figure 3.

Figure 3

Expression of SKOR2 in pulmonary adenocarcinoma. (A, B) A lung biopsy from patient 1 (Diagnosed with pulmonary adenocarcinoma) shows neoplastic cells (indicated with arrows) with a high nuclear/cytoplasmic (N/C) ratio (H/E staining, high-power image in (B)). (C, D) Immunohistochemistry reveals variable cytoplasmic SKOR2 immunoreactivities in the neoplastic cells. (E, F) A negative control by omitting the primary antibody shows no signal in the following section. Scale bars: 200 μm (A, C, E); 50 μm (B, D, F).